Psychiatric Comorbidities and Schizophrenia in Youths With Attention-Deficit/Hyperactivity Disorder

被引:4
|
作者
Jeon, Soo Min [1 ]
Lee, Dong Yun [2 ]
Cha, Sanghun [3 ]
Kwon, Jin-Won [4 ,5 ,6 ]
机构
[1] Jeju Natl Univ, Coll Pharm, Jeju, South Korea
[2] Ajou Univ, Sch Med, Dept Biomed Informat, Suwon, South Korea
[3] Kyungpook Natl Univ, Coll Nat Sci, Dept Stat, Daegu, South Korea
[4] Kyungpook Natl Univ, Coll Pharm, BK21 FOUR Community Based Intelligent Novel Drug D, Daegu, South Korea
[5] Kyungpook Natl Univ, Res Inst Pharmaceut Sci, 80 Daehak Ro, Daegu 41566, South Korea
[6] Kyungpook Natl Univ, Coll Pharm, 80 Daehak Ro, Daegu 41566, South Korea
关键词
DEFICIT HYPERACTIVITY DISORDER; BIPOLAR DISORDER; PSYCHOTIC DISORDER; RISK; ADULTS; ADHD; DEPRESSION; RECOVERY; SYMPTOMS; BIRTH;
D O I
10.1001/jamanetworkopen.2023.45793
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE The association between attention-deficit/hyperactivity disorder (ADHD) and schizophrenia has received increased attention; however, evidence on the association between psychiatric comorbidities and subsequent schizophrenia in patients with ADHD is limited.OBJECTIVE To investigate the risk of being diagnosed with schizophrenia in children and adolescents with ADHD considering the presence of psychiatric comorbidity.DESIGN, SETTING, AND PARTICIPANTS This was a population-based, retrospective cohort study using the Health Insurance Review and Assessment claims database from January 1, 2007, to December 31, 2019. Participants were children and adolescents aged 5 to 19 years who received an ADHD diagnosis between January 1, 2010, and December 31, 2018, in the nationwide claims data of Korea. Data were analyzed from January 2010 to December 2019.INTERVENTIONS OR EXPOSURES The presence of psychiatric comorbidity was assessed from diagnosis records within 1 year before ADHD diagnosis. Comorbidities were further categorized according to the number of comorbidities and specific comorbid disorders.MAIN OUTCOMES AND MEASURES Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95% CIs, examining the association between psychiatric comorbidities and the risk of being diagnosed with schizophrenia. Furthermore, the occurrence of psychiatric comorbidity during the follow-up period was explored among patients without psychiatric comorbidity at baseline.RESULTS A total of 211705 patients with newly diagnosed ADHD were included. A total of 157 272 patients (74.3%) were male, and the age of 5 to 9 years showed the highest distribution (115 081 patients [54.4%]). Patients with psychiatric comorbidity had a significantly higher risk of being diagnosed with schizophrenia than those without (adjusted HR, 2.14; 95% CI, 2.05-2.23). The association between schizophrenia and psychiatric comorbidity became progressively greater with the increasing number of comorbidities. Several individual psychiatric disorders showed an association with development of schizophrenia, with ASD, intellectual disability, tic disorder, depression, and bipolar disorder being the top 5 disorders most associated. Furthermore, 3244 patients (73.8%) without psychiatric comorbidities experienced the emergence of other psychiatric disorders before schizophrenia occurrence.CONCLUSIONS AND RELEVANCE In this retrospective cohort study involving children and adolescents with ADHD, the presence of psychiatric comorbidity in patients with ADHD was associated with an increased risk of being diagnosed with schizophrenia, with an increased risk observed in multiple comorbidities and a wide variety of comorbidities. These findings highlight the significance of assessing and managing psychiatric comorbidities in patients with ADHD to decrease subsequent schizophrenia risk and allow for early intervention.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Attention-deficit/hyperactivity disorder
    Petermann, Franz
    Hampel, Petra
    KINDHEIT UND ENTWICKLUNG, 2009, 18 (03): : 135 - 136
  • [42] Attention-Deficit Hyperactivity Disorder
    Bahn, Geon-Ho
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2005, 48 (11): : 1110 - 1118
  • [43] Attention-deficit/hyperactivity disorder
    Schweitzer, JB
    Cummins, TK
    Kant, CA
    MEDICAL CLINICS OF NORTH AMERICA, 2001, 85 (03) : 757 - +
  • [44] Attention-deficit/hyperactivity disorder
    Spencer, TJ
    ARCHIVES OF NEUROLOGY, 2002, 59 (02) : 314 - 316
  • [45] Attention-deficit disorder with hyperactivity
    Ryan, MG
    MEDICAL JOURNAL OF AUSTRALIA, 1996, 165 (03) : 173 - 174
  • [46] ATTENTION-DEFICIT HYPERACTIVITY DISORDER
    WIENER, JM
    PSYCHIATRIC ANNALS, 1989, 19 (11) : 574 - 575
  • [47] Attention-deficit hyperactivity disorder
    Thapar, AK
    Thapar, A
    BRITISH JOURNAL OF GENERAL PRACTICE, 2003, 53 (488): : 225 - 230
  • [48] Attention-deficit/hyperactivity disorder
    Faraone, Stephen V.
    Asherson, Philip
    Banaschewski, Tobias
    Biederman, Joseph
    Buitelaar, Jan K.
    Ramos-Quiroga, Josep Antoni
    Rohde, Luis Augusto
    Sonuga-Barke, Edmund J. S.
    Tannock, Rosemary
    Franke, Barbara
    NATURE REVIEWS DISEASE PRIMERS, 2015, 1
  • [49] Attention-deficit hyperactivity disorder
    Biederman, J
    Faraone, SV
    LANCET, 2005, 366 (9481): : 237 - 248
  • [50] Attention-deficit/hyperactivity disorder
    Torres Mohedas, J.
    Villares Alonso, R.
    NEUROLOGIA, 2008, : 9 - 14